The Embalmer Analysis Results Will Blow Your Mind

Vejon Health
4 Sept 202413:58

Summary

TLDRA group of anonymous scientists have released a document detailing unusual blood clot patterns observed in embalming fluid, which they believe requires urgent investigation. The clots, first noticed in 2021, are reported to occur in both the deceased and the living, with characteristics significantly different from normal clots. The implications are grave, suggesting that standard treatments for clot-related conditions may become less effective. The scientific community is urged to acknowledge and investigate these findings to mitigate potential risks to public health.

Takeaways

  • πŸ”¬ A group of anonymous scientists has been researching unusual blood clots and has produced a document detailing their findings, which they believe is critical for further investigation.
  • πŸ€” The scientists are concerned about the implications of their work for their personal and professional lives, hence their decision to remain anonymous.
  • 🧬 They have observed an unusual pattern of blood clots, primarily in 2021, which has not been widely acknowledged or investigated by the medical community.
  • πŸ‘¨β€βš•οΈ The script suggests that doctors and scientists should be more curious and proactive in investigating these clots, as ignoring them could be negligent.
  • 🩸 A whistleblower from a cath lab in the US confirmed that the unusual clots are not only found in embalming fluid but also in living individuals.
  • πŸ‘€ The document shared by the scientists includes detailed analysis and images of the clots, indicating that they are very different from normal blood clots.
  • πŸ“Š The analysis shows that the clots have abnormal protein compositions, including fibrinogen beta, gamma, and alpha, which could suggest a different clotting mechanism.
  • ⚠️ The implications of these findings are serious, as they could indicate that standard treatments for clots may become less effective, and that even blood thinners might not be as effective.
  • πŸ‘΄ The document includes data from clots taken from individuals of different ages and genders, suggesting that the phenomenon is not limited to a specific demographic.
  • πŸ” The script calls for further scientific investigation and discussion to understand the mechanisms behind these clots and to mitigate their potential impact on public health.

Q & A

  • What has the group of scientists been investigating over the past year?

    -The group of scientists has been investigating the unusual occurrence of blood clots, particularly focusing on their characteristics and implications.

  • Why have the scientists been working quietly on this research?

    -The scientists have been working quietly due to anxiety about the potential personal and professional implications of their findings.

  • What is the significance of the document they have shared publicly?

    -The document is significant because it contains critical information and observations that the scientists believe necessitate further investigation into the unusual pattern of blood clots.

  • Why are the scientists remaining anonymous?

    -The scientists are remaining anonymous to protect their identities, likely due to the controversial nature of their findings and potential backlash.

  • What is the 'unusual pattern' mentioned in the script?

    -The 'unusual pattern' refers to the observation of blood clots that are different from the norm, which has primarily been noticed since 2021.

  • Why is the whistleblower's message significant?

    -The whistleblower's message is significant because it confirms that the occurrence of these unusual blood clots is not limited to a specific group but is also happening in the general living population.

  • What did the analysis of the blood clots reveal?

    -The analysis revealed that the blood clots had unusual characteristics, including differences in the proteins involved and the way they form, which is distinct from standard clots.

  • What are the potential implications if these blood clots are not studied further?

    -If these blood clots are not studied further, there could be serious implications for public health, including ineffective standard treatments for clot-related conditions and an increased risk of clot-related events.

  • What is the role of the medical community in addressing this issue?

    -The medical community has a responsibility to investigate these findings, understand any changes in disease presentation, and adapt treatments accordingly to mitigate the risks associated with these unusual blood clots.

  • Why is it important not to dismiss these findings as a conspiracy theory?

    -It is important not to dismiss these findings as a conspiracy theory because they are based on real evidence and have potential serious implications for health and treatment efficacy. Dismissing them could lead to overlooking a significant public health issue.

  • What is the significance of the 19-inch long clot mentioned in the script?

    -The 19-inch long clot is significant because it represents an abnormal and unusually large blood clot, which further emphasizes the need for understanding the mechanisms behind these occurrences.

Outlines

00:00

🧬 Silent Scientific Investigation into Embus Clots

A group of anonymous scientists has been investigating the phenomenon of embus clots, which they believe could have significant implications for public health. They have published a document detailing their findings, which they consider critical for further research. The scientists have observed an unusual pattern that has largely been ignored by others in the field. The speaker emphasizes the importance of this research, suggesting that it is a matter of professional responsibility to raise awareness about these clots, even if it means risking their own careers. The document includes images and data that are compelling and warrant further investigation. The speaker also discusses a whistleblower from a cath lab who confirmed the occurrence of these clots in living individuals, which was a significant revelation that shifted the perspective on the issue.

05:00

πŸ”¬ Unusual Characteristics of Embus Clots

The scientists have discovered that the characteristics of embus clots are markedly different from those of normal clots. They have analyzed four different embus clots, each from a different individual, and found abnormal protein ratios and compositions. The document suggests that these clots contain a different main constituent, which may indicate a unique mechanism behind their formation. The scientists are calling for further analysis by experts in the field of clotting to understand these findings better. The implications of these findings are significant, as they suggest that standard treatments for clot-related conditions may become less effective if these unusual clots continue to occur.

10:02

🚨 Urgent Need for Medical Community Awareness

The speaker stresses the urgency for the medical community to acknowledge and investigate the phenomenon of embus clots. They argue that the potential implications of these clots are so serious that ignoring them could lead to higher risk events and ineffective treatments. The speaker calls for clinicians to observe and report any changes in the presentation of clot-related diseases and to consider the possibility that current medications may not be as effective as they once were. The document and the whistleblower interview serve as evidence that this is not a conspiracy theory but a real and present issue that requires immediate attention and action.

Mindmap

Keywords

πŸ’‘Embus clots

Embus clots refer to blood clots that form within the circulatory system, specifically in the veins. In the context of the video, these clots are described as having unusual characteristics and are a central focus of the scientists' investigation. The video mentions that these clots are not only occurring in the deceased but also in the living, which raises serious concerns about potential changes in human physiology and the effectiveness of current treatment methods.

πŸ’‘Anomaly

An anomaly is something that deviates from what is standard, normal, or expected. The video discusses an 'unusual pattern' observed in embus clots, which has prompted further investigation. The anomaly is significant because it challenges the understanding of blood clot formation and may indicate a shift in the way clot-related diseases present themselves.

πŸ’‘Whistleblower

A whistleblower is a person who exposes secretive information or activity that is deemed illegal, unethical, or not correct within a private or public organization. In the video, a whistleblower working in a cath lab in the US confirms the occurrence of unusual clots, adding credibility to the claims made by the scientists and highlighting the potential risks associated with these clots.

πŸ’‘Pathophysiology

Pathophysiology is the study of the functional changes that occur in the body as a result of disease. The video emphasizes the need to understand the pathophysiology of the unusual embus clots to determine their mechanisms and possibly mitigate their effects. This understanding is crucial for developing effective treatments and managing the health risks associated with these clots.

πŸ’‘Fibrinogen

Fibrinogen is a protein that plays a key role in the blood clotting process. The video mentions fibrinogen as one of the proteins involved in the formation of the unusual embus clots. The presence and ratio of fibrinogen in these clots are highlighted as significant in understanding their composition and the potential reasons behind their formation.

πŸ’‘Thrombolysis

Thrombolysis is a medical procedure used to break down blood clots by administering drugs that activate enzymes that dissolve the clot. The video suggests that standard thrombolysis may not be as effective against the unusual embus clots, indicating a potential shift in the treatment paradigm for clot-related conditions.

πŸ’‘Blood thinners

Blood thinners, also known as anticoagulants, are medications that help prevent blood clots from forming or growing larger. The video raises concerns that even individuals on blood thinners might be experiencing clotting issues, suggesting that the effectiveness of these medications could be compromised in the presence of the unusual embus clots.

πŸ’‘Pulmonary embolus

A pulmonary embolus is a blockage in one of the pulmonary arteries in the lungs, usually caused by a blood clot that travels to the lungs from another part of the body. The video discusses the potential impact of the unusual embus clots on the occurrence and treatment of pulmonary embolus, which could lead to a change in the standard presentation and management of this condition.

πŸ’‘Ethical responsibility

Ethical responsibility refers to the moral obligation one has to act in a way that is right and just. The video emphasizes the scientists' and medical professionals' ethical responsibility to investigate and address the unusual embus clots to protect public health and ensure the effectiveness of medical treatments.

πŸ’‘Substack

Substack is a platform for writers to create subscription-based newsletters. In the video, the host mentions a Substack link in the description, which likely contains more detailed information or discussions about the embus clots. This platform is used to disseminate the findings and engage with an audience interested in the topic.

πŸ’‘Kickstarter

Kickstarter is a crowdfunding platform where creators can raise funds for their projects. The video mentions a Kickstarter program related to 'Disease X,' which may be connected to the research on embus clots. This suggests that the investigation into these clots is part of a broader effort to understand and address emerging health threats.

Highlights

Scientists have been working quietly to understand embus clots.

They have produced a document that could be groundbreaking for further investigations.

The scientists must remain anonymous due to personal and professional concerns.

An unusual pattern of embus clots primarily occurred in 2021, with no clear explanation.

The scientists have a responsibility to raise awareness about their findings.

A whistleblower from a cath lab in the US confirmed clot occurrences in the living.

The analysis of embus clots showed characteristics very different from normal clots.

The clots contain an important clotting protein in a way not seen in normal clots.

The clots have a very fibrous and elastic feel, which is unusual.

The implications of ignoring these findings could lead to higher risk events in the future.

Standard treatment methods may not be as effective against these unusual clots.

The medical community has a responsibility to check for changes in disease presentation.

The situation is likened to an 'elephant in the room' that needs acknowledgment and addressing.

The document provides a comprehensive view of the potential mechanisms behind the clots.

The scientists have broken down the science to understand what could be happening with the clots.

The findings are not a conspiracy theory but real evidence of abnormal clot patterns.

There is a call to action for understanding and mitigating the impact of these clots.

The Whistleblower video provides further evidence and should be viewed for more information.

Transcripts

play00:04

over the past year a group of scientists

play00:08

have been working quietly behind the

play00:11

scenes trying to figure out exactly what

play00:15

has been happening with embus clots

play00:19

they've been doing this work quietly and

play00:22

consistently because they are so anxious

play00:26

about what it could mean for themselves

play00:28

personally and in their profession

play00:30

work but what it means is that they've

play00:33

finally come up with a document that

play00:37

will absolutely blow your mind now

play00:41

listen very carefully they have to

play00:43

remain anonymous and that's going to be

play00:45

one of the challenges that we face is

play00:47

that people are going to say you need to

play00:49

show who you are but what they have done

play00:52

is they have put together a document

play00:54

which they have now shared publicly

play00:57

which they believe is absolutely

play00:59

critical for further investigations to

play01:02

be done you have to remember that there

play01:05

is an unusual pattern here and the

play01:08

unusual pattern is that nobody seems to

play01:10

be interested in what the Embers are

play01:14

observing now some people may say well

play01:17

the ambers are not doctors and they are

play01:20

not scientists why are they talking

play01:23

about it the reality is that they have

play01:26

observed something that was unusual at

play01:30

transition that primarily occurred in

play01:32

2021 and they don't have an explanation

play01:35

for it my view is that if they hadn't

play01:38

raised awareness for it that would be

play01:41

negligent they had the responsibility to

play01:44

do that but not everyone is interested

play01:47

in looking at these outcomes and so it

play01:50

raises very very serious questions now I

play01:54

keep on talking about it and you may

play01:56

wonder why do I keep on raising this

play02:00

issue about imas clots what really is in

play02:04

it what am I focused on why do I keep on

play02:07

doing

play02:08

it well a few months ago after I had

play02:13

done the original interview with regards

play02:16

to embance clots where I had done with

play02:18

Tom havland and his survey um

play02:22

outcomes um a few months later I was

play02:26

contacted by somebody who worked in a

play02:28

cath lab in the us and this individual

play02:33

confirmed that not only were these clots

play02:36

occurring with the Embers but they were

play02:39

occurring with the living now this was a

play02:42

whistleblower message meaning that he

play02:44

didn't give his identity away and

play02:48

therefore what that means is that he put

play02:51

his job at risk I feel a tremendous

play02:54

sense of responsibility with that and

play02:57

that's part of the reason why I keep

play02:59

talking about it I feel as to have been

play03:02

given that responsibility to raise

play03:04

awareness about this this is really the

play03:07

substack the link is in the description

play03:10

this is where we had the interview with

play03:12

the Whistleblower myself and Dr Shetty

play03:15

and he shared with us a number of images

play03:18

that were quite stunning um for everyone

play03:22

to see so if you want to see the full

play03:24

video you need to go at the description

play03:26

I'll not show you any more simply

play03:28

because some people are squeamish and

play03:30

they don't necessarily want to see the

play03:32

clots but it was a very very important

play03:35

interview because it highlighted that

play03:38

this was occurring in the

play03:41

living now when I saw that that changed

play03:44

my perspective completely because I

play03:46

realized that we have to therefore

play03:49

understand the mechanisms the

play03:52

pathophysiology in order to try and see

play03:54

if we can mitigate what could be quite

play03:58

significant occurrences

play04:00

now when they looked at the analysis

play04:03

they took into consideration that it had

play04:06

been done as well previously so there

play04:09

was a Mike Adams who did some work early

play04:13

on and this was after the died suddenly

play04:16

presentation and he was looking at the

play04:19

clot analysis at that time and it shows

play04:22

you the details of the things that he

play04:24

had seen in the blood and he had

play04:26

compared it with regards to BAS line his

play04:30

own blood his own blood clot to see what

play04:33

was the difference between them and so

play04:36

this analysis had been done early in

play04:39

2021 but since then nothing else had

play04:42

been done so these scientists

play04:47

went got more ous clots and they then

play04:51

did further more detailed analysis to

play04:54

try and figure out what in the world was

play04:57

going on I'm not doing the analysis here

play05:00

now because that will take some real

play05:03

indepth discussion and talk and my hope

play05:05

is to try and get a number of scientists

play05:07

who are expert in the field of clotting

play05:10

for them to go through the analysis and

play05:12

try and see if they can make sense of

play05:15

what it is that they are finding the

play05:18

important thing to note is that they

play05:20

have observed that the characteristics

play05:23

of these ous clots are very different

play05:27

from normal standard clots

play05:30

and here is some of the just to give you

play05:33

a little bit of a taste of what is in

play05:35

this document here they were looking at

play05:38

four embus clots and they were showing

play05:42

some of the characteristic abnormalities

play05:44

or the proteins that were involved in

play05:47

them fibrinogen beta gamma Alpha and the

play05:49

ratios this was very important and

play05:52

helped them to formulate a theory as to

play05:54

what they thought was going on and they

play05:57

showed a breakdown of the main

play06:00

constituents for each of the four

play06:02

samples this one here was a young

play06:04

teenage female this one here was a 25y

play06:07

old male this one here was a 40-year-old

play06:10

they don't know the gender and this one

play06:12

here was a 70-year old male what I've

play06:16

realized is that there does seem to be

play06:18

some difference in the constituents the

play06:20

main constituents so it suggests that

play06:23

the mechanism that is associated with

play06:26

these clots is partially about the main

play06:30

constituents but there are going to be

play06:32

minor constituencies um constituents in

play06:35

the clot that give it that

play06:37

characteristic very fibrous elastic feel

play06:41

that is very unusual and as I said I'm

play06:44

not going to give you the main breakdown

play06:46

at the moment but one of the things that

play06:49

they had noted is that one of the

play06:51

important clotting proteins as a whole

play06:54

gets incorporated into these clots it's

play06:57

not just in the pieces as would normally

play06:59

happen in a normal clot there is

play07:02

something very unusual about them that's

play07:05

the reality and to ignore the fact that

play07:09

they are occurring is extremely

play07:12

unscientific I genuinely can't

play07:14

understand anyone who is not curious

play07:17

about what could be the cause it's one

play07:19

thing to say that you don't believe that

play07:22

the eners are seeing it and some people

play07:25

genuinely think that they think they've

play07:26

just made it up and maybe they've got

play07:28

some put or something and they've put

play07:31

these clots just to get attention that

play07:33

could be one small possibility but this

play07:36

is not a oneoff and they have collected

play07:39

hundreds of samples from across the

play07:41

world there is something very strange

play07:44

happening and it needs to be

play07:47

delineated even more worryingly this

play07:49

pattern seems to be also occurring in

play07:52

people we therefore really have to

play07:55

understand why is it happening the

play07:58

outcomes of not doing that are going to

play08:02

be that we're going to see a transition

play08:05

in the type of presentation that we

play08:07

would normally see people always get

play08:10

clots with a pulmonary embolus or even a

play08:13

stroke um or an embolic phenomenon

play08:16

blocking an outra to a

play08:18

leg if this is continuing to occur in

play08:21

the living what you will then see is

play08:24

that your standard methods of treatment

play08:27

are no longer as effective

play08:30

you will find that thrombolysis will not

play08:32

work effectively you will find that when

play08:35

they try to break up these clots by you

play08:38

know using local measures it still

play08:41

doesn't work additionally if this

play08:44

information is correct it will indicate

play08:48

that quite likely even the blood

play08:50

thinness that people are on will not be

play08:53

as

play08:53

effective so if you are noticing

play08:57

patterns that say for instance people

play09:00

who are on blood thinners for clotting

play09:03

problems and they are still clotting on

play09:05

a regular basis that's a red flag that

play09:09

indicates that something has changed in

play09:12

the human physiology that is not as easy

play09:16

to address even with

play09:18

medication so the implications of not

play09:22

looking at this are very serious it will

play09:25

mean that people have higher risk events

play09:28

in the near future if they are not

play09:31

already happening and so there is a

play09:33

responsibility on the medical community

play09:36

if they hear about this to first check

play09:40

and see whether or not there has been a

play09:44

transition in the way that disease is

play09:47

presenting that's the responsibility

play09:49

clinically and doctors should know this

play09:52

nurses will probably know this as well

play09:54

are they seeing the same type of disease

play09:56

is it the same way is there a concern

play09:59

concern with the way how patients are

play10:01

presenting these are the kinds of

play10:03

questions that need to be answered quite

play10:06

urgently and without those answers we're

play10:09

putting everyone at risk fundamentally I

play10:13

think that what is happening is that

play10:15

there is a general

play10:17

anxiety about dealing with what we call

play10:21

the elephant in the room now without

play10:25

actually reflecting carefully it is

play10:28

concerning and I can understand that but

play10:31

there is an elephant that is sitting

play10:33

around and that elephant is not being

play10:36

acknowledged and without acknowledgment

play10:39

of the elephant there is no chance to

play10:41

mitigate against the impact it has on

play10:43

the couch or the room that's the

play10:46

situation that we have

play10:47

today what is happening is that people

play10:50

are afraid to ask the questions because

play10:52

of the implications if the answers are

play10:56

correct I understand that but at the end

play11:00

of the day the people who should be most

play11:03

concerned are not clinicians because

play11:06

they have just followed the rules and

play11:08

the system they have a responsibility

play11:11

now to make sure that if there is an

play11:15

elephant it is observed acknowledged and

play11:18

addressed we're going to start and

play11:21

continue this process of asking these

play11:23

hard questions remember as I said this

play11:27

is no longer just

play11:29

Theory we have now got clear evidence

play11:34

that something is abnormal with regards

play11:36

to these clots this is quite a

play11:38

comprehensive view of what they have

play11:41

done and they have looked in a lot of

play11:43

detail as to the potential mechanism

play11:46

this is a picture of one of the clots

play11:48

that they had it was 19 in long this is

play11:52

definitely not a normal pattern and what

play11:56

they have done in this document is that

play11:58

they have broken down the science as to

play12:01

what they think could be happening as I

play12:03

said that's a conversation for another

play12:06

period of time and certainly something

play12:08

that we have to check with regards to

play12:11

Scientific experts as to their own

play12:13

thoughts on it but the point is this

play12:16

don't let anyone tell you that this is a

play12:19

conspiracy theory this is real this is

play12:23

having an impact and we need to

play12:26

understand as quickly as we can how this

play12:30

can be

play12:31

mitigated so there is still a lot of

play12:33

work ahead of us but we appreciate your

play12:36

support and as usual remember to

play12:38

subscribe look in the description we are

play12:41

coming towards the final stages of our

play12:44

Kickstarter program about disease X

play12:47

we're about halfway there in terms of

play12:49

our funding targets and please join us

play12:53

in this process at to getting this out

play12:55

there all of this is relevant to what is

play12:58

happening at the moment moment if we

play13:00

understand the science and prepare for

play13:02

the science and try and mitigate it with

play13:04

everything that we have around us we

play13:07

have the best chance of making a

play13:09

difference for ourselves and our loved

play13:11

ones so thank you again and look out for

play13:15

more information about these embus clots

play13:19

and I tell you if you haven't seen The

play13:21

Whistleblower video you must click on

play13:25

the description and see exactly what he

play13:27

said about what was going going on have

play13:30

a great evening

play13:32

[Music]

Rate This
β˜…
β˜…
β˜…
β˜…
β˜…

5.0 / 5 (0 votes)

Related Tags
Blood ClotsHealth MysteryScientific ResearchMedical AnomaliesWhistleblowerPublic HealthClot AnalysisMedical ProfessionalsHealth AwarenessDisease Patterns